Development of a new MS-based biomarker for the early and sensitive diagnosis of Glycogen storage disease using the technique of Mass-spectometry 7,5 ml EDTA blood, saliva tube and a dry blood spot filter card

Testing for clinical robustness, specificity and long-term stability of the biomarker

100

All

2 Months and older (Child, Adult, Older Adult)

NCT02385162

BGL 01/2015

BioGlycogen

March 2015

March 2020

April 2020

March 11, 2015

July 5, 2017

Albrecht-Kossel-Institute for Neuroregeneration (AKos) Centre for Mental Health Disease University of RostockRostock, Germany

The aim of the present study is to determine if there is a change in quality and quantity of sleep perceived by GSD adults and children and their parents while starting a modified UCCS (Glycosade) to prevent nocturnal hypoglycaemia.

To evaluate if there is a change in quality of life perceived by GSD adults and children and their parents with Glycosade.